Drug Trial News

RSS

Birth order not a factor in multiple sclerosis risk

A new Canadian study suggests that the youngest children in a family are not less likely than older siblings to develop multiple sclerosis (MS).

22 Aug 2005

Epidemiological study links heart protection with non-aspirin, non-steroidal drugs

It is well known that aspirin, a non-selective, non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX), reduces the risk of heart attack and stroke.

22 Aug 2005

Study shows potential treatment for brain cancer

A compound that kills cancer can sneak past the blood brain barrier, which protects the brain from foreign substances, to do its work in fighting a particularly invasive brain cancer, according to a new Saint Louis University animal study published in the Proceedings of the National Academy of Sciences Online Early Edition the week of Aug. 22.

22 Aug 2005

$Propofol is a safe and effective drug to treat children with refractory status epilepticus$

Propofol is a safe and effective drug to treat children with refractory status epilepticus

...and it is recommended before thiopental, according to a study in the August 23, 2005 issue of Neurology, the scientific journal of the American Academy of Neurology. Propofol and thiopental are widely used intravenous anesthetics which are also known to help control seizures.

22 Aug 2005

Heart healthy habits are good for oral health

Heart healthy habits are good for oral health, too, according to a new study published in the current issue of the Journal of Periodontology, the official publication of the American Academy of Periodontology.

22 Aug 2005

Australian employers can save up to $1 Billion lost every year by assisting employees with untreated depression

Depression is the leading cause of disability in Australia with one in five Australians suffering a major depression episode during their life time spelling a miserable time for a large group of people.

22 Aug 2005

Experimental vaccine can prime the immune system to help fight an aggressive form of lymphoma

Researchers at The University of Texas M. D. Anderson Cancer Center and the National Cancer Institute have found that an experimental vaccine can prime the immune system to help fight an aggressive form of lymphoma, even though prior therapy had eliminated virtually all of the B cells thought necessary to mount such a defense.

22 Aug 2005

Antidepressant drug should have suicide warning for adults as well as children

According to a Norwegian study, adults taking the antidepressant drug paroxetine are at a higher risk of attempting to commit suicide than those not taking medication.

22 Aug 2005

Health benefits of different types of language use and writing contexts now explored

Researchers have known for some time that expressive writing can have a positive effect on the writer's health, such as illness recovery.

22 Aug 2005

Nearly one-third of former brain tumor patients require special education services

Children who survive brain cancer struggle for years with the malevolent echo of the disease and its treatment, according to a new study from the Stanford University School of Medicine and Lucile Packard Children's Hospital.

22 Aug 2005

A cell's energy level is critical to its survival

In an ongoing effort to fight disease by manipulating energy regulation of cells, a collaborative study led by Dartmouth Medical School (DMS) has demonstrated that cells lacking a tumor-suppressing kinase called LKB1 can still maintain healthy energy levels when they become stressed.

22 Aug 2005

Non-invasive imaging may help predict type 1 diabetes and response to treatment in humans

A key obstacle to early detection of type 1 diabetes - as well as to rapid assessment of the effectiveness of therapeutic intervention - has been the lack of direct, non-invasive technologies to visualize inflammation in the pancreas, an early manifestation of disease.

22 Aug 2005

Novel vaccine strain with high efficacy against tuberculosis

Tuberculosis remains a major global health threat. Although more than 3 billion doses of the BCG vaccine have been administered to fight tuberculosis, the ability of the BCG vaccine to protect adults is very limited, as is its efficacy against newly emerging isolates.

22 Aug 2005

Paroxetine linked to higher rate of suicide

Adult patients taking the antidepressant drug paroxetine are at higher risk of attempting to commit suicide than those not taking medication.

22 Aug 2005

Early clinical signs of ovarian cancer

Many women diagnosed with ovarian cancer actually complained of symptoms of the disease at least four months before they were diagnosed, according to a new study to be published in the October 1, 2005 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

22 Aug 2005

Many phase I trials for new cancer fighting drugs never get reported in peer-reviewed journals

A new study finds many phase I trials for new cancer fighting drugs never get reported in peer-reviewed journals, and says investigators should be committed not just to finding novel compounds, but also to make sure final results of their studies be disseminated to the medical community.

22 Aug 2005

Detailed picture of migraines

Every eight adult Swede suffers from migraine. Using a new method, researchers at Göteborg have managed for the first time ever to provide a detailed picture of an untreated attack. This will be of great significance for the development of new forms of treatment.

22 Aug 2005

Phase I cancer findings under-reported

Phase I cancer studies, trials that are conducted to determine the safety and maximum dose of a new agent, are under-reported in peer-reviewed journals - a trend that could ultimately delay scientific progress and negatively affect patient care, say researchers at The University of Texas M. D. Anderson Cancer Center in a new study out today (Mon., Aug, 22) online in Cancer.

22 Aug 2005

Protein Sirt1 points to new therapies for type 2 diabetes

Opening the possibility of new therapies for type 2 diabetes, researchers at Washington University School of Medicine in St. Louis have found that a protein called Sirt1 enhances the secretion of insulin in mice and allows them to better control blood glucose levels. Their study appears in the August 17 issue of Cell Metabolism.

18 Aug 2005

Magazines aimed at African-American and Hispanic women publish twice as many adverts for potentially health-damaging products

A study published in the open access journal, BMC Public Health, shows that the content of advertisements in black or Latino magazines may contribute to the lower health status observed in African-American and Hispanic populations in the USA.

18 Aug 2005

Drug Trial News

Birth order not a factor in multiple sclerosis risk

Epidemiological study links heart protection with non-aspirin, non-steroidal drugs

Study shows potential treatment for brain cancer

Propofol is a safe and effective drug to treat children with refractory status epilepticus

Heart healthy habits are good for oral health

Australian employers can save up to $1 Billion lost every year by assisting employees with untreated depression

Experimental vaccine can prime the immune system to help fight an aggressive form of lymphoma

Antidepressant drug should have suicide warning for adults as well as children

Health benefits of different types of language use and writing contexts now explored

Nearly one-third of former brain tumor patients require special education services

A cell's energy level is critical to its survival

Non-invasive imaging may help predict type 1 diabetes and response to treatment in humans

Novel vaccine strain with high efficacy against tuberculosis

Paroxetine linked to higher rate of suicide

Early clinical signs of ovarian cancer

Many phase I trials for new cancer fighting drugs never get reported in peer-reviewed journals

Detailed picture of migraines

Phase I cancer findings under-reported

Protein Sirt1 points to new therapies for type 2 diabetes

Magazines aimed at African-American and Hispanic women publish twice as many adverts for potentially health-damaging products

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News